🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/03/2005 | 30,39 | 30,57 | 29,98 | 30,57 | +1,01% | 1,95% | 11.821.859 |
| 17/03/2005 | 30,18 | 30,35 | 30,08 | 30,27 | +0,06% | 0,92% | 6.922.040 |
| 16/03/2005 | 30,53 | 30,67 | 30,08 | 30,25 | -0,94% | 1,94% | 7.939.543 |
| 15/03/2005 | 31,01 | 31,01 | 30,49 | 30,53 | -0,90% | 1,69% | 6.597.370 |
| 14/03/2005 | 30,72 | 30,91 | 30,53 | 30,81 | +0,40% | 1,21% | 5.804.872 |
| 11/03/2005 | 30,80 | 30,85 | 30,55 | 30,69 | +0,00% | 0,96% | 6.419.629 |
| 10/03/2005 | 30,52 | 30,80 | 30,41 | 30,69 | +1,04% | 1,28% | 8.163.291 |
| 09/03/2005 | 30,29 | 30,49 | 30,11 | 30,37 | +0,32% | 1,23% | 7.738.851 |
| 08/03/2005 | 30,30 | 30,48 | 30,21 | 30,28 | +0,09% | 0,88% | 7.031.661 |
| 07/03/2005 | 30,30 | 30,33 | 30,11 | 30,25 | +0,06% | 0,72% | 8.031.243 |
| 04/03/2005 | 30,24 | 30,32 | 29,77 | 30,23 | +0,32% | 1,83% | 7.674.399 |
| 03/03/2005 | 30,21 | 30,26 | 29,68 | 30,13 | -0,06% | 1,93% | 7.524.430 |
| 02/03/2005 | 30,39 | 30,45 | 29,87 | 30,15 | -1,65% | 1,92% | 9.807.813 |
| 01/03/2005 | 30,59 | 30,72 | 30,37 | 30,66 | +1,36% | 1,12% | 9.794.503 |
| 28/02/2005 | 30,44 | 30,55 | 29,93 | 30,25 | -0,63% | 2,04% | 15.183.843 |
| 25/02/2005 | 30,34 | 30,69 | 30,08 | 30,44 | -0,28% | 2,01% | 8.671.781 |
| 24/02/2005 | 30,34 | 30,55 | 30,11 | 30,52 | +0,72% | 1,48% | 7.883.266 |
| 23/02/2005 | 30,10 | 30,53 | 29,85 | 30,31 | +1,76% | 2,28% | 12.927.499 |
| 22/02/2005 | 31,11 | 31,11 | 29,75 | 29,78 | -4,29% | 4,36% | 37.655.583 |
| 18/02/2005 | 28,13 | 31,12 | 28,13 | 31,12 | +13,03% | 10,62% | 61.549.354 |
| 17/02/2005 | 27,69 | 27,77 | 27,19 | 27,53 | -0,59% | 2,10% | 8.507.664 |
| 16/02/2005 | 27,77 | 27,84 | 27,45 | 27,69 | -1,12% | 1,41% | 8.778.677 |
| 15/02/2005 | 27,94 | 28,35 | 27,81 | 28,01 | -0,20% | 1,95% | 8.108.690 |
| 14/02/2005 | 27,78 | 28,10 | 27,69 | 28,06 | +0,68% | 1,48% | 7.001.898 |
| 11/02/2005 | 27,43 | 28,00 | 27,38 | 27,87 | +1,56% | 2,26% | 9.129.128 |
| 10/02/2005 | 27,48 | 27,62 | 27,19 | 27,44 | +0,21% | 1,56% | 6.847.946 |
| 09/02/2005 | 27,48 | 27,89 | 27,30 | 27,39 | -0,35% | 2,15% | 9.854.763 |
| 08/02/2005 | 27,01 | 27,52 | 26,97 | 27,48 | +1,30% | 2,05% | 9.414.813 |
| 07/02/2005 | 26,91 | 27,53 | 26,86 | 27,13 | +0,28% | 2,48% | 10.627.558 |
| 04/02/2005 | 27,11 | 27,17 | 26,93 | 27,05 | -0,21% | 0,88% | 9.223.134 |